The maker of Tylenol, Listerine, Neutrogena, Band-Aids and Benadryl plans a global headquarters in New Jersey with over 3,000 scientists and other employees over the next few years.
The New Jersey-based drugmaker said it expected annual earnings of $8.53 to $8.65 per share, up from its previous forecast of $8.44 to $8.59. Analysts had estimated earnings of $8.56 per share.
Walgreens will start working directly with drugmakers to bring cell and gene therapies to U.S. patients as part of a broader effort to expand its specialty pharmacy services.
DOJ is conducting a criminal investigation into consulting firm McKinsey related to its past role in advising some of the nation's largest opioid makers on how to boost sales.
The state's treasurer is taking on drugmakers Novo Nordisk and Eli Lilly in an attempt to lower drug costs for the state. So far, neither side is satisfied.